Centre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, Canada.
Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.
Autophagy. 2021 Dec;17(12):3924-3938. doi: 10.1080/15548627.2021.1896925. Epub 2021 Mar 10.
Coxsackievirus B3 (CVB3) is a prevalent etiological agent for viral myocarditis and neurological disorders, particularly in infants and young children. Virus-encoded proteinases have emerged as cytopathic factors that contribute to disease pathogenesis in part through targeting the cellular recycling machinery of autophagy. Although it is appreciated that CVB3 can usurp cellular macroautophagy/autophagy for pro-viral functions, the precise mechanisms by which viral proteinases disrupt autophagy remain incompletely understood. Here we identified TFEB (transcription factor EB), a master regulator of autophagy and lysosome biogenesis, as a novel target of CVB3 proteinase 3 C. Time-course infections uncovered a significant loss of full-length TFEB and the emergence of a lower-molecular mass (~63 kDa) fragment. Cellular and cleavage assays revealed the involvement of viral proteinase 3 C in the proteolytic processing of TFEB, while site-directed mutagenesis identified the site of cleavage after glutamine 60. Assessment of TFEB transcriptional activity using a reporter construct discovered a loss of function of the cleavage fragment despite nuclear localization and retaining of the ability of DNA and protein binding. Furthermore, we showed that CVB3 infection was also able to trigger cleavage-independent nuclear translocation of TFEB that relied on the serine-threonine phosphatase PPP3/calcineurin. Finally, we demonstrated that both TFEB and TFEB [Δ60] serve roles in viral egress albeit through differing mechanisms. Collectively, this study reveals that CVB3 targets TFEB for proteolytic processing to disrupt host lysosomal function and enhance viral infection.ACTB: actin beta; CLEAR: coordinated lysosomal enhancement and regulation; CVB3: coxsackievirus B3; DAPI: 4',6-diamidino-2-phenylindole; GFP: green fluorescent protein; LAMP1: lysosomal associated membrane protein 1; LTR: LysoTracker Red; PPP3/calcineurin: protein phosphatase 3; PPP3CA: protein phosphatase 3 catalytic subunit A; p-TFEB: phospho-Ser211 TFEB; si-CON: scramble control siRNA; TFEB: transcription factor EB; TFEB [Δ60]: TFEB cleavage fragment that lacks the first 60 amino acids; VP1: viral capsid protein 1.
柯萨奇病毒 B3 (CVB3) 是病毒性心肌炎和神经紊乱的主要病因,尤其是在婴儿和幼儿中。病毒编码的蛋白酶已成为细胞病变因子,部分通过靶向自噬的细胞再循环机制,导致疾病的发病机制。尽管人们已经认识到 CVB3 可以为病毒功能而篡夺细胞巨自噬/自噬,但病毒蛋白酶破坏自噬的确切机制仍不完全清楚。在这里,我们鉴定了 TFEB(转录因子 EB),一种自噬和溶酶体生物发生的主要调节剂,作为 CVB3 蛋白酶 3C 的新靶标。时程感染揭示了全长 TFEB 的显著丢失和出现较低分子量 (~63 kDa) 片段。细胞和切割分析表明,病毒蛋白酶 3C 参与了 TFEB 的蛋白水解加工,而定点突变分析确定了谷氨酰胺 60 后的切割位点。使用报告基因构建体评估 TFEB 转录活性发现,尽管核定位和保留 DNA 和蛋白质结合的能力,但切割片段的功能丧失。此外,我们还表明,CVB3 感染也能够触发不依赖于切割的 TFEB 核易位,这依赖于丝氨酸-苏氨酸磷酸酶 PPP3/calcineurin。最后,我们证明了 TFEB 和 TFEB [Δ60] 都在病毒出芽中起作用,尽管通过不同的机制。总的来说,这项研究揭示了 CVB3 靶向 TFEB 进行蛋白水解加工,以破坏宿主溶酶体功能并增强病毒感染。ACTB:肌动蛋白 β;CLEAR:协调溶酶体增强和调节;CVB3:柯萨奇病毒 B3;DAPI:4',6-二脒基-2-苯基吲哚;GFP:绿色荧光蛋白;LAMP1:溶酶体相关膜蛋白 1;LTR:LysoTracker Red;PPP3/calcineurin:蛋白磷酸酶 3;PPP3CA:蛋白磷酸酶 3 催化亚基 A;p-TFEB:磷酸化-Ser211 TFEB;si-CON: scramble 对照 siRNA;TFEB:转录因子 EB;TFEB [Δ60]:缺少前 60 个氨基酸的 TFEB 切割片段;VP1:病毒衣壳蛋白 1。